Published in Exp Biol Med (Maywood) on December 16, 2014
The human digestive tract has proteases capable of gluten hydrolysis. Mol Metab (2017) 0.75
Structural basis for gluten intolerance in celiac sprue. Science (2002) 8.16
Single-disk antibiotic-sensitivity testing of staphylococci; an analysis of technique and results. AMA Arch Intern Med (1959) 3.82
Oral microbial communities in sickness and in health. Trends Microbiol (2005) 3.40
Celiac disease: from pathogenesis to novel therapies. Gastroenterology (2009) 2.84
Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut (2007) 1.75
Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol (2006) 1.68
HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest (2006) 1.66
Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res (2005) 1.63
Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel Dis (2001) 1.56
Characterization of Bacillus probiotics available for human use. Appl Environ Microbiol (2004) 1.48
Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut (2012) 1.37
Rational design of combination enzyme therapy for celiac sprue. Chem Biol (2006) 1.28
Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. J Immunol (2004) 1.23
Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo. J Pharmacol Exp Ther (2004) 1.19
Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol (2008) 1.13
Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Ann Intern Med (2013) 1.11
The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes. PLoS One (2010) 1.05
Oral enzyme therapy for celiac sprue. Methods Enzymol (2012) 1.03
Meta-analysis on anxiety and depression in adult celiac disease. Acta Psychiatr Scand (2011) 1.01
Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci (2013) 1.01
Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity. PLoS One (2010) 1.00
Celiac disease and autoimmune-associated conditions. Biomed Res Int (2013) 0.99
Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract. PLoS One (2011) 0.96
Gluten: a two-edged sword. Immunopathogenesis of celiac disease. Springer Semin Immunopathol (2005) 0.95
The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity. Clin Microbiol Infect (2013) 0.95
Studies of intestinal lymphoid tissue: the cytology and electron microscopy of gluten-sensitive enteropathy, with particular reference to its immunopathology. Scand J Gastroenterol Suppl (1981) 0.95
A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. J Proteome Res (2009) 0.93
Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation. BMC Genomics (2012) 0.91
Non-celiac gluten sensitivity. Is it in the gluten or the grain? J Gastrointestin Liver Dis (2013) 0.91
Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial. J Med Microbiol (2013) 0.91
Microbiological profiles in saliva and supragingival plaque from caries-active adolescents before and after a short-term daily intake of milk supplemented with probiotic bacteria - a pilot study. Oral Health Prev Dent (2010) 0.90
Celiac disease: advances in treatment via gluten modification. Clin Gastroenterol Hepatol (2012) 0.90
Bone mass and mineral metabolism alterations in adult celiac disease: pathophysiology and clinical approach. Nutrients (2013) 0.88
Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics. Cancer Lett (2013) 0.87
Should we be 'nervous' about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurological opinion. J Neurol Neurosurg Psychiatry (2012) 0.86
Gluten intolerance (coeliac disease). Ann Allergy (1984) 0.85
Causes of short stature identified in children presenting at a tertiary care hospital in Multan Pakistan. Pak J Med Sci (2013) 0.85
A comparison between two different in vitro basophil activation tests for gluten- and cow's milk protein sensitivity in irritable bowel syndrome (IBS)-like patients. Clin Chem Lab Med (2013) 0.84
Gluten ataxia: an important treatable etiology of sporadic ataxia. Int J Neurosci (2012) 0.82
Risk of thyroid cancer in a nationwide cohort of patients with biopsy-verified celiac disease. Thyroid (2013) 0.78
[Lactulose plus live binary Bacillus subtilis in the treatment of elders with functional constipation]. Zhonghua Yi Xue Za Zhi (2012) 0.76
In vitro mucosal digestion of synthetic gliadin-derived peptides in celiac disease. J Protein Chem (1995) 0.76
Enhanced viability of Lactobacillus reuteri for probiotics production in mixed solid-state fermentation in the presence of Bacillus subtilis. Folia Microbiol (Praha) (2013) 0.76
Epilepsy in coeliac disease: not just a matter of calcifications. Neurol Sci (2011) 0.76